230 related articles for article (PubMed ID: 5056666)
1. The interaction of Hageman factor and immune complexes.
Cochrane CG; Wuepper KD; Aiken BS; Revak SD; Spiegelberg HL
J Clin Invest; 1972 Oct; 51(10):2736-45. PubMed ID: 5056666
[TBL] [Abstract][Full Text] [Related]
2. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
3. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
Treloar MP; Pyle H; Ozge-Anwar AH; Takeuchi Y; Movat HZ
Eur J Immunol; 1972 Aug; 2(4):338-45. PubMed ID: 5083514
[No Abstract] [Full Text] [Related]
4. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
[TBL] [Abstract][Full Text] [Related]
5. Activation of Hageman factor by collagen.
Wilner GD; Nossel HL; LeRoy EC
J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
[TBL] [Abstract][Full Text] [Related]
6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
7. The autoactivation of rabbit Hageman factor.
Wiggins RC; Cochrane CC
J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
[TBL] [Abstract][Full Text] [Related]
8. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
9. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
[TBL] [Abstract][Full Text] [Related]
10. The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.
Revak SD; Cochrane CG
J Clin Invest; 1976 Apr; 57(4):852-60. PubMed ID: 947956
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
13. A radioimmunoassay for human antigen-antibody complexes in clinical material.
Cowdery JS; Treadwell PE; Fritz RB
J Immunol; 1975 Jan; 114(1 Pt 1):5-9. PubMed ID: 1167561
[TBL] [Abstract][Full Text] [Related]
14. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
Cochrane CG; Wuepper KD
J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
[TBL] [Abstract][Full Text] [Related]
15. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
España F; Ratnoff OD
J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
17. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses.
Henson PM; Spiegelberg HL
J Clin Invest; 1973 May; 52(5):1282-8. PubMed ID: 4700496
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.
Rothberger H; Zimmerman TS; Spiegelberg HL; Vaughan JH
J Clin Invest; 1977 Mar; 59(3):549-57. PubMed ID: 190271
[TBL] [Abstract][Full Text] [Related]
19. Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor.
Tesar JT; Schmid FR
J Immunol; 1970 Nov; 105(5):1206-14. PubMed ID: 5312663
[No Abstract] [Full Text] [Related]
20. [Isolation and some properties of Hageman factor and its active fragment from human blood].
Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
